Full Version | Search

The Irish Medicines Board - www.imb.ie

IMB Logo

Levemir FlexPen & NovoRapid FlexPen - Important Safety Information from Novo Nordisk following approval by the IMB

02 February 2009

Please find attached safety information communication from Novo Nordisk regarding the importance of highlighting the differences between these products to patients administering them as part of the treatment of diabetes.

Important Safety Information-Levemir FlexPen and NovoRapid FlexPen





Date Printed: 20 May 2013

© Irish Medicines Board 2013 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971